Eric A. Gehrie

3.1k total citations
87 papers, 1.2k citations indexed

About

Eric A. Gehrie is a scholar working on Biochemistry, Hematology and Management of Technology and Innovation. According to data from OpenAlex, Eric A. Gehrie has authored 87 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Biochemistry, 36 papers in Hematology and 24 papers in Management of Technology and Innovation. Recurrent topics in Eric A. Gehrie's work include Blood transfusion and management (41 papers), Blood groups and transfusion (25 papers) and Blood donation and transfusion practices (24 papers). Eric A. Gehrie is often cited by papers focused on Blood transfusion and management (41 papers), Blood groups and transfusion (25 papers) and Blood donation and transfusion practices (24 papers). Eric A. Gehrie collaborates with scholars based in United States, Canada and Spain. Eric A. Gehrie's co-authors include Paul M. Ness, Christopher A. Tormey, Aaron A.R. Tobian, Evan M. Bloch, Garrett S. Booth, Steven M. Frank, Michael Laposata, Bipin N. Savani, Charles D. Bolan and Jeanne E. Hendrickson and has published in prestigious journals such as Blood, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Eric A. Gehrie

81 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric A. Gehrie United States 19 482 425 286 215 183 87 1.2k
Ruchika Goel United States 19 560 1.2× 430 1.0× 264 0.9× 255 1.2× 217 1.2× 101 1.4k
Kjell Titlestad Denmark 18 368 0.8× 330 0.8× 321 1.1× 153 0.7× 184 1.0× 37 1.0k
Torunn Oveland Apelseth Norway 17 723 1.5× 479 1.1× 417 1.5× 494 2.3× 114 0.6× 57 1.3k
Elizabeth M. Love United Kingdom 15 652 1.4× 373 0.9× 335 1.2× 328 1.5× 163 0.9× 30 1.1k
James R. Stubbs United States 22 741 1.5× 445 1.0× 384 1.3× 810 3.8× 159 0.9× 93 1.8k
D. Stainsby United Kingdom 14 890 1.8× 413 1.0× 397 1.4× 648 3.0× 153 0.8× 23 1.4k
Kathleen Sazama United States 14 482 1.0× 333 0.8× 283 1.0× 195 0.9× 140 0.8× 45 1.1k
Steve Kleinman United States 24 513 1.1× 472 1.1× 286 1.0× 154 0.7× 337 1.8× 47 1.5k
Amanda Thomson Australia 12 215 0.4× 304 0.7× 145 0.5× 135 0.6× 130 0.7× 27 791
Louise Choo United Kingdom 13 381 0.8× 415 1.0× 126 0.4× 164 0.8× 254 1.4× 21 920

Countries citing papers authored by Eric A. Gehrie

Since Specialization
Citations

This map shows the geographic impact of Eric A. Gehrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Gehrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Gehrie more than expected).

Fields of papers citing papers by Eric A. Gehrie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Gehrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Gehrie. The network helps show where Eric A. Gehrie may publish in the future.

Co-authorship network of co-authors of Eric A. Gehrie

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Gehrie. A scholar is included among the top collaborators of Eric A. Gehrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Gehrie. Eric A. Gehrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adkins, Brian D., Garrett S. Booth, Ross M. Fasano, et al.. (2024). Eliminating leukocyte reduction for whole blood: Is it premature to consider this paradigm‐changing practice?. Transfusion. 65(2). 375–378.
2.
Gehrie, Eric A., Pampee P. Young, Sridhar V. Basavaraju, et al.. (2024). Addressing platelet insecurity – A national call to action. Transfusion. 64(10). 2001–2013. 6 indexed citations
3.
Valentini, Caterina Giovanna, Luciana Teofili, & Eric A. Gehrie. (2024). Iron metabolism in sickle cell disease patients undergoing chronic red blood cell exchange: A delicate homeostasis in balance. British Journal of Haematology. 205(4). 1257–1259.
4.
Bahar, Burak, et al.. (2023). Measuring the Impact of a Blood Supply Shortage Using Data Science. The Journal of Applied Laboratory Medicine. 8(1). 77–83. 1 indexed citations
5.
Goel, Ruchika, Xianming Zhu, Cassandra D. Josephson, et al.. (2023). Pediatric firearm injury related emergency department visits and hospitalizations: a population-based study in the United States. The Lancet Regional Health - Americas. 22. 100503–100503. 6 indexed citations
6.
Lee, Edward S., et al.. (2023). P‐TS‐5 | Adverse Event Outcomes of 6‐Day‐Stored Pathogen‐Reduced Platelet Transfusion. Transfusion. 63(S5). 1 indexed citations
7.
Snyder, Edward L., et al.. (2023). P‐TS‐64 | Pathogen‐Reduced Platelet Storage for 6‐Days to Mitigate Acute‐on‐Chronic Platelet Shortages. Transfusion. 63(S5). 1 indexed citations
8.
Bahar, Burak, et al.. (2023). Using trends and outliers in managing delayed transfusions. Transfusion Medicine. 33(3). 263–267. 1 indexed citations
9.
Jacobs, Jeremy W., Matthew S. Karafin, Elizabeth S. Allen, et al.. (2022). Blood conservation strategies at United States hospitals during the COVID‐19 pandemic: Findings from a multi‐institutional analysis ‐ International Society of Blood Transfusion survey. Transfusion. 62(11). 2271–2281. 8 indexed citations
10.
Frank, Steven M., Tymoteusz J. Kajstura, N.C. Cruz, et al.. (2020). Balancing the Blood Component Transfusion Ratio for High- and Ultra High–Dose Cell Salvage Cases. Journal of Cardiothoracic and Vascular Anesthesia. 35(4). 1060–1066. 4 indexed citations
11.
Gehrie, Eric A., et al.. (2020). Transfusion Service Response to the COVID-19 Pandemic. American Journal of Clinical Pathology. 154(3). 280–285. 19 indexed citations
12.
Kacker, Seema, Evan M. Bloch, Paul M. Ness, et al.. (2019). Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions. Transfusion. 59(4). 1291–1299. 17 indexed citations
13.
Gehrie, Eric A., et al.. (2019). Pathogen Reduction. Hematology/Oncology Clinics of North America. 33(5). 749–766. 9 indexed citations
14.
Blakemore, Karin J., Luca A. Vricella, Priya Sekar, et al.. (2018). Prenatal ABO/RHD Genotyping: A New Paradigm to Allow for Fresh Whole Blood for Cardiopulmonary Bypass in the Immediate Newborn Period. Fetal Diagnosis and Therapy. 44(2). 156–159. 2 indexed citations
15.
Amin, Raj M., Eric A. Gehrie, Ruchika Goel, et al.. (2018). Patient Blood Management Program Improves Blood Use and Clinical Outcomes in Orthopedic Surgery. Anesthesiology. 129(6). 1082–1091. 44 indexed citations
16.
Gehrie, Eric A., et al.. (2017). Detecting Pharmaceuticals in the Red Blood Cell Inventory of a Hospital Blood Bank. The Journal of Pediatrics. 189. 227–231.e1. 4 indexed citations
17.
Gehrie, Eric A., Ian Baine, & Garrett S. Booth. (2016). Pathology Consultation on Viscoelastic Studies of Coagulopathic Obstetrical Patients: Table 1. American Journal of Clinical Pathology. 146(2). 149–155. 4 indexed citations
19.
Gehrie, Eric A., et al.. (2011). Profound piperacillin‐mediated drug‐induced immune hemolysis in a patient with cystic fibrosis. Transfusion. 52(1). 4–5. 7 indexed citations
20.
Gehrie, Eric A., William van der Touw, Jonathan S. Bromberg, & Jordi Ochando. (2010). Plasmacytoid Dendritic Cells in Tolerance. Methods in molecular biology. 677. 127–147. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026